(Q34296075)

1 August 2017

1 reference

title

Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders (English)

1 reference

1 August 2017

W P Spooren

1

1 reference

1 August 2017

F Gasparini

series ordinal

2

1 reference

1 August 2017

T E Salt

series ordinal

3

1 reference

1 August 2017

R Kuhn

series ordinal

4

1 reference

1 August 2017

1 July 2001

1 reference

Trends in Pharmacological Sciences

1 August 2017

1 reference

1 August 2017

22

1 reference

1 August 2017

331-337

1 reference

1 August 2017

7

1 reference

Pharmacology and functions of metabotropic glutamate receptors

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Cellular localization of a metabotropic glutamate receptor in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Synaptic activation of the group I metabotropic glutamate receptor mGlu1 on the thalamocortical neurons of the rat dorsal lateral geniculate nucleus in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Contributions of mGlu1 and mGlu5 receptors to interactions with N-methyl-D-aspartate receptor-mediated responses and nociceptive sensory responses of rat thalamic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Pharmacology of metabotropic glutamate receptor-mediated enhancement of responses to excitatory and inhibitory amino acids on rat spinal neurones in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

The function of metabotropic excitatory amino acid receptors in synaptic transmission in the thalamus: studies with novel phenylglycine antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901694-1

7 January 2021

10.1016/S0165-6147(00)01694-1

Identifiers

DOI

1 reference

release_jlblv2vsivdm3dyx3ekzxgfnuy

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jlblv2vsivdm3dyx3ekzxgfnuy

24 November 2022

mapped directly with Wikidata item

1 reference